These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9139799)

  • 1. The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction.
    Davis DP; Rozell TG; Liu X; Segaloff DL
    Mol Endocrinol; 1997 May; 11(5):550-62. PubMed ID: 9139799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor.
    Rozzell TG; Wang H; Liu X; Segaloff DL
    Mol Endocrinol; 1995 Dec; 9(12):1727-36. PubMed ID: 8614409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor.
    Abell A; Liu X; Segaloff DL
    J Biol Chem; 1996 Feb; 271(8):4518-27. PubMed ID: 8626807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding.
    Thomas D; Rozell TG; Liu X; Segaloff DL
    Mol Endocrinol; 1996 Jun; 10(6):760-8. PubMed ID: 8776736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mutations of the lutropin/choriogonadotropin receptor that impair signal transduction also interfere with receptor-mediated endocytosis.
    Dhanwada KR; Vijapurkar U; Ascoli M
    Mol Endocrinol; 1996 May; 10(5):544-54. PubMed ID: 8732685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the Lutropin/Choriogonadotropin receptor.
    Min KS; Liu X; Fabritz J; Jaquette J; Abell AN; Ascoli M
    J Biol Chem; 1998 Dec; 273(52):34911-9. PubMed ID: 9857020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone.
    Wang Z; Liu X; Ascoli M
    Mol Endocrinol; 1997 Feb; 11(2):183-92. PubMed ID: 9013765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors.
    Quintana J; Wang H; Ascoli M
    Mol Endocrinol; 1993 Jun; 7(6):767-75. PubMed ID: 8395653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone-binding properties and glycosylation pattern of a recombinant form of the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor expressed in mammalian cells.
    Thomas DM; Segaloff DL
    Endocrinology; 1994 Nov; 135(5):1902-12. PubMed ID: 7956911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function.
    Davis D; Liu X; Segaloff DL
    Mol Endocrinol; 1995 Feb; 9(2):159-70. PubMed ID: 7776966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization, and enhance agonist-induced receptor down-regulation.
    Wang Z; Hipkin RW; Ascoli M
    Mol Endocrinol; 1996 Jun; 10(6):748-59. PubMed ID: 8776735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfected cells express mostly the intracellular precursor of the lutropin/choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity.
    Fabritz J; Ryan S; Ascoli M
    Biochemistry; 1998 Jan; 37(2):664-72. PubMed ID: 9425089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of truncations of the cytoplasmic tail of the luteinizing hormone/chorionic gonadotropin receptor on receptor-mediated hormone internalization.
    Rodriguez MC; Xie YB; Wang H; Collison K; Segaloff DL
    Mol Endocrinol; 1992 Mar; 6(3):327-36. PubMed ID: 1316539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive charges in a putative amphiphilic helix in the carboxyl-terminal region of the third intracellular loop of the luteinizing hormone/chorionic gonadotropin receptor are not required for hormone-stimulated cAMP production but are necessary for expression of the receptor at the plasma membrane.
    Wang H; Jaquette J; Collison K; Segaloff DL
    Mol Endocrinol; 1993 Nov; 7(11):1437-44. PubMed ID: 8114758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA; Narayan P; Huang J; Puett D
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues.
    Galet C; Ascoli M
    Mol Endocrinol; 2005 May; 19(5):1263-76. PubMed ID: 15677709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of potential sites for N-linked glycosylation does not impair hormone binding to the lutropin/choriogonadotropin receptor if Asn-173 is left intact.
    Liu X; Davis D; Segaloff DL
    J Biol Chem; 1993 Jan; 268(3):1513-6. PubMed ID: 8420926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature sensitivity of some mutants of the lutropin/choriogonadotropin receptor.
    Jaquette J; Segaloff DL
    Endocrinology; 1997 Jan; 138(1):85-91. PubMed ID: 8977389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor.
    Angelova K; Narayan P; Simon JP; Puett D
    Mol Endocrinol; 2000 Apr; 14(4):459-71. PubMed ID: 10770485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dileucine-based motif in the C-terminal tail of the lutropin/choriogonadotropin receptor inhibits endocytosis of the agonist-receptor complex.
    Nakamura K; Ascoli M
    Mol Pharmacol; 1999 Oct; 56(4):728-36. PubMed ID: 10496955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.